rs17128525
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001354483.2(CSGALNACT1):c.-296-365G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.416 in 152,110 control chromosomes in the GnomAD database, including 13,847 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.42 ( 13847 hom., cov: 32)
Consequence
CSGALNACT1
NM_001354483.2 intron
NM_001354483.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.39
Publications
1 publications found
Genes affected
CSGALNACT1 (HGNC:24290): (chondroitin sulfate N-acetylgalactosaminyltransferase 1) This gene encodes an enzyme that transfers N-acetylglucosamine (GalNAc) to the core tetrasaccharide linker and to elongating chondroitin sulfate chains in proteoglycans. Knockout of the orthologous mouse gene indicates that the protein is necessary for normal cartilage development and aggrecan metabolism. Mutations in this gene are associated with multiple sclerosis progression, and with mild skeletal dysplasia and joint laxity. [provided by RefSeq, Aug 2017]
CSGALNACT1 Gene-Disease associations (from GenCC):
- skeletal dysplasia, mild, with joint laxity and advanced bone ageInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.549 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CSGALNACT1 | NM_001354483.2 | c.-296-365G>A | intron_variant | Intron 2 of 8 | ENST00000692225.2 | NP_001341412.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.416 AC: 63182AN: 151992Hom.: 13813 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
63182
AN:
151992
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.416 AC: 63262AN: 152110Hom.: 13847 Cov.: 32 AF XY: 0.413 AC XY: 30729AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
63262
AN:
152110
Hom.:
Cov.:
32
AF XY:
AC XY:
30729
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
23014
AN:
41470
American (AMR)
AF:
AC:
4797
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
1232
AN:
3468
East Asian (EAS)
AF:
AC:
844
AN:
5182
South Asian (SAS)
AF:
AC:
2242
AN:
4820
European-Finnish (FIN)
AF:
AC:
3660
AN:
10566
Middle Eastern (MID)
AF:
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26155
AN:
67990
Other (OTH)
AF:
AC:
753
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1854
3708
5561
7415
9269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1094
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.